Related Experiment Videos
Gout and hyperuricemia
1Department of Internal Medicine, The University of Oklahoma College of Medicine, Tulsa 74135, USA. Robert-wortmann@ouhsc.edu
Insights
Gout and hyperuricemia are global health issues, influenced by genetics and lifestyle factors like diet and obesity. Effective urate removal is key to managing gout, with allopurinol and uricosuric agents offering treatment options.
Area of Science:
- Rheumatology
- Metabolic Diseases
- Public Health
Background:
- Gout remains a significant global health concern despite available treatments.
- Prevalence is increasing, particularly in African and Oriental countries, linked to genetic factors, alcohol, obesity, and hypertension.
- Hyperuricemia is associated with cardiovascular disease, potentially mediated by insulin resistance, explaining comorbidities like hyperlipidemia and glucose intolerance in gout patients.
Purpose of the Study:
- To review the current understanding of gout and hyperuricemia prevalence and contributing factors.
- To discuss the relationship between hyperuricemia, metabolic syndrome components, and cardiovascular disease.
- To highlight treatment strategies for gout, focusing on urate-lowering therapies and managing associated conditions.
Main Methods:
- Literature review of studies on gout, hyperuricemia, and associated metabolic and cardiovascular conditions.
- Analysis of factors influencing gout prevalence, including genetics, lifestyle, and comorbidities.
- Evaluation of current therapeutic approaches, including urate-lowering agents and lifestyle modifications.
Main Results:
- Genetic factors play a role, but lifestyle factors like alcohol consumption, obesity, and hypertension significantly contribute to gout and hyperuricemia prevalence.
- Insulin resistance links hyperuricemia to cardiovascular disease, explaining the frequent co-occurrence of hyperlipidemia and glucose intolerance in gout patients.
- Dietary manipulation, alongside management of hypertension and obesity, is crucial for gout patients. Allopurinol is a primary urate-lowering agent, but allergic reactions necessitate alternatives like uricosuric agents.
Conclusions:
- Comprehensive management of gout requires addressing lifestyle factors and comorbidities, not just acute attacks.
- Effective urate removal is essential for gout elimination, with ongoing development of treatment strategies for patients intolerant to allopurinol.
- Further research into alternative urate-lowering therapies and personalized management plans for gout patients is warranted.
Abstract:
Gout continues to be a health problem around the world despite the availability of effective therapies. Although the prevalence is influenced by genetic factors, the associations of alcohol consumption, obesity, and hypertension appear to be partially responsible for the increased prevalence of gout and hyperuricemia in African and Oriental countries. The association between hyperuricemia and cardiovascular disease seems linked to insulin resistance. This relation, in part, explains the common coexistence of hyperlipidemia and glucose intolerance in patients with gout. Accordingly, it is recommended that one pay more attention to dietary manipulation in patients with gout in addition to managing hypertension, obesity, and other medical problems. Although acute gout attacks can be treated, eliminating gout requires effective removal of urate from the body. Allopurinol remains a dominant urate-lowering agent, however its use may be limited by allergic reactions. Uricosuric agents are also effective urate-lowering agents and provide an alternative to allopurinol. Strategies to treat patients who are sensitive to allopurinol continue to evolve.